The Hidden Burden of Hemifacial Spasm: A Systematic Review of Non-Motor Symptoms
Abstract
Background: Hemifacial spasm (HFS) is a chronic neurological disorder characterized by involuntary contractions of facial muscles. Traditionally regarded as a motor condition, HFS encompasses a spectrum of non-motor symptoms that are often overlooked but significantly affect patients' quality of life.
Objectives: This systematic review aimed to synthesize current evidence on the prevalence and clinical relevance of non-motor manifestations in HFS.
Methods: A systematic search was conducted across PubMed, Cochrane, and EMBASE databases up to June 29, 2025, following PRISMA guidelines. Eligible studies included cross-sectional, cohort, case-control, and case series designs reporting pain, psychiatric symptoms, or sleep disturbances in HFS. Risk of bias was assessed using the Joanna Briggs Institute critical appraisal tools according to study design.
Results: Twenty-two studies met inclusion criteria. Headache was reported in varying frequencies, ranging from 24.2% to 60% of cases, and facial pain in 33.3%, both frequently improving after botulinum toxin (BoNT) therapy. Psychiatric comorbidities were prevalent, with depression and anxiety reported in 5.7% to 29% and 9.1% to 19.5% of patients, respectively. Sleep disorders, mainly insomnia, occurred up to three times more often in HFS patients than in controls. BoNT therapy demonstrated beneficial effects beyond motor control, reducing pain, anxiety, and depressive symptoms.
Conclusion: HFS is a multidimensional disorder with…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.